Q3'FY24 Revenue at Rs. 449 crores is up by 28% on a y-o-y basis. 9M revenue of Rs. 1277 crores, is up 21%.
API total revenue at Rs. 253 Crores for Q3 is up by 20% on a y-o-y basis, whereas for a 9M period at Rs. 668 Crores
Q3 revenue for the Formulation business at Rs. 65 crores is up by 40% whereas, for 9 months period, revenue growth is at 22% for Rs. 166 Crores
Domestic revenue for the Q3 at Rs. 271 crores is up by 27%. For the 9M period, at Rs. 829 Crores, revenue growth is at 30%
Revenues growth is at 10%. API Q3 exports at Rs. 176 Crores are up by 31% while Domestic Business is up only 1%.
The medical devices business continues its high growth journey with 24% revenue growth in Q3 and a 37% jump in the 9M period.
Q3'FY24 Revenue at Rs. 449 crores is up by 28% on a y-o-y basis. 9M revenue of Rs. 1277 crores, is up 21%.
Domestic revenue for the Q3 at Rs. 271 crores is up by 27%. For the 9M period, at Rs. 829 Crores, revenue growth is at 30%
API total revenue at Rs. 253 Crores for Q3 is up by 20% on a y-o-y basis, whereas for a 9M period at Rs. 668 Crores
Revenues growth is at 10%. API Q3 exports at Rs. 176 Crores are up by 31% while Domestic Business is up only 1%.
Q3 revenue for the Formulation business at Rs. 65 crores is up by 40% whereas, for 9 months period, revenue growth is at 22% for Rs. 166 Crores
The medical devices business continues its high growth journey with 24% revenue growth in Q3 and a 37% jump in the 9M period.
Morepen - The Future of Home Diagnostics and OTC Health Products
India Pharma Outlook
Dr. Morepen launches advanced Muscle Food to fuel your performance
The Pharma Times
Dr. Morepen launches advanced Pre-workout Muscle Food to fuel your performance
Business Gujarat News
Empowering Health. Everywhere
Morepen is dedicated to providing affordable, high-quality healthcare solutions through innovative pharmaceutical and medical technology products. We strive to make health accessible for all and achieve a global reach.
Excellence. Passion. Action. Innovation
Morepen is driven by a commitment to excellence in everything we do. Our three core values – Passion, Action, and Innovation – guide our actions. We prioritize delivering superior quality products, efficient distribution networks, and exceptional customer service. We are a passionate and results-oriented team, leveraging technology for continuous research and development. Our goal is to remain at the forefront of healthcare solutions.
Annual Return
Annual Secretarial Compliance Report
Newspaper Advertisements